Esperion Therapeutics, Inc. ESPR 5.75 06.15.30
CONVERTIBLE BOND · US DOMESTIC · CUSIP 29664WAD7
1
institutional holders
4.6m
shares reported held*
$5.6mreported value*
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.21.
Biggest buyers
| Meteora Capital, LLC | New | +4.6m |
Biggest sellers
| None |
Holders, Q2 2026
| Manager | Shares | Change |
|---|---|---|
| Meteora Capital, LLC 0.46% of their portfolio | 4.6m $5.6m | New |